Shelly Carter

3.1k total citations
25 papers, 2.1k citations indexed

About

Shelly Carter is a scholar working on Hematology, Genetics and Transplantation. According to data from OpenAlex, Shelly Carter has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Genetics and 7 papers in Transplantation. Recurrent topics in Shelly Carter's work include Hematopoietic Stem Cell Transplantation (16 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Acute Myeloid Leukemia Research (6 papers). Shelly Carter is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Acute Myeloid Leukemia Research (6 papers). Shelly Carter collaborates with scholars based in United States, Canada and Netherlands. Shelly Carter's co-authors include Mary M. Horowitz, Robert J. Soiffer, Vincent T. Ho, Adam Mendizabal, Joanne Kurtzberg, Paul J. Martin, Corey Cutler, Sergio Giralt, Kristin Page and James L.M. Ferrara and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Shelly Carter

25 papers receiving 2.1k citations

Peers

Countries citing papers authored by Shelly Carter

Since Specialization

Citations

This map shows the geographic impact of Shelly Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly Carter more than expected).

Fields of papers citing papers by Shelly Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelly Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly Carter. The network helps show where Shelly Carter may publish in the future.

Co-authorship network of co-authors of Shelly Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Shelly Carter. A scholar is included among the top collaborators of Shelly Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelly Carter. Shelly Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers 2014 ·New England Journal of Medicine ·John E. Wagner, Mary Eapen, Shelly Carter, Yanli Wang, Kirk R. Schultz, Donna A. Wall, Nancy Bunin, Colleen Delaney, Paul R. Haut, David M. Margolis, Edward Peres, Michael R. Verneris, Mark C. Walters, Mary M. Horowitz, Joanne Kurtzberg	170
2	Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial 2013 ·Journal of Clinical Oncology ·Julie M. Vose, Shelly Carter, Linda J. Burns, Ernesto Ayala, Oliver W. Press, Craig H. Moskowitz, Edward A. Stadtmauer, (unknown), Richard F. Ambinder, Timothy S. Fenske, Mary M. Horowitz, Richard I. Fisher, Marcie Tomblyn	113
3	Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2012 ·Biology of Blood and Marrow Transplantation ·Naynesh Kamani, Mark C. Walters, Shelly Carter, Victor Aquino, Joel A. Brochstein, Sonali Chaudhury, Mary Eapen, Brian M. Freed, Michael Grimley, John E. Levine, Brent R. Logan, Theodore B. Moore, Julie A. Panepinto, Suhag Parikh, Michael A. Pulsipher, Jane Sande, Kirk R. Schultz, Stephen R. Spellman, Shalini Shenoy	142
4	Comparative Outcomes of Donor Graft CD34⁺ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation 2012 ·Journal of Clinical Oncology ·Marcelo C. Pasquini, Steven M. Devine, Adam Mendizabal, Lindsey R. Baden, John R. Wingard, Hillard M. Lazarus, Frederick R. Appelbaum, Carolyn A. Keever-Taylor, Mary M. Horowitz, Shelly Carter, Richard J. O’Reilly, Robert J. Soiffer	106
5	Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303 2011 ·Biology of Blood and Marrow Transplantation ·Carolyn A. Keever-Taylor, Steven M. Devine, Robert J. Soiffer, Adam Mendizabal, Shelly Carter, Marcelo C. Pasquini, Parameswaran Hari, Anthony S. Stein, Hillard M. Lazarus, Charles Linker, Steven C. Goldstein, Edward A. Stadtmauer, Richard J. O’Reilly	49
6	Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303 2011 ·Biology of Blood and Marrow Transplantation ·Steven M. Devine, Shelly Carter, Robert J. Soiffer, Marcelo C. Pasquini, Parameswaran Hari, Anthony S. Stein, Hillard M. Lazarus, Charles Linker, Edward A. Stadtmauer, Edwin P. Alyea, Carolyn A. Keever-Taylor, Richard J. O’Reilly	104
7	Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment after Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis of 435 Cord Blood Transplants 2011 ·Biology of Blood and Marrow Transplantation ·Kristin Page, Lijun Zhang, Adam Mendizabal, Stephen Wease, Shelly Carter, Tracy Gentry, Andrew E. Balber, Joanne Kurtzberg	118
8	The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME) 2011 ·Transfusion ·Kristin Page, Lijun Zhang, Adam Mendizabal, Stephen Wease, Shelly Carter, Kevin Shoulars, Tracy Gentry, Andrew E. Balber, Joanne Kurtzberg	31
9	HLA-Identical Sibling-Matched, CD34+ Selected, T Cell Depleted Peripheral Blood Stem Cells Following Myeloablative Conditioning for First or Second Remission Acute Myeloid Leukemia (AML): Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303. 2009 ·Blood ·Steven M. Devine, Robert J. Soiffer, Marcelo C. Pasquini, Shelly Carter, Parameswaran Hari, Stephanie DeVore, Anthony S. Stein, Hillard M. Lazarus, Charles Linker, Edward A. Stadtmauer, Carolyn A. Keever-Taylor, Richard J. O’Reilly	4
10	Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network 2009 ·Blood ·Amin M. Alousi, Daniel J. Weisdorf, Brent R. Logan, Javier Bolaños‐Meade, Shelly Carter, Nancy DiFronzo, Marcelo C. Pasquini, Steven C. Goldstein, Vincent T. Ho, Brandon Hayes‐Lattin, John R. Wingard, Mary M. Horowitz, John E. Levine	147
11	Use of biological assignment in hematopoietic stem cell transplantation clinical trials 2008 ·Clinical Trials ·Brent R. Logan, Eric Leifer, Christopher Bredeson, Mary M. Horowitz, Marian Ewell, Shelly Carter, Nancy L. Geller	14
12	Social Support, Optimism, and Self-Efficacy Predict Physical and Emotional Well-Being After Bone Marrow Transplantation 2007 ·Journal of Psychosocial Oncology ·(unknown), Elizabeth M. Altmaier, Richard P. McQuellon, Stella M. Davies, (unknown), Shelly Carter, Jean Henslee-Downey	60
13	Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions 2007 ·Biology of Blood and Marrow Transplantation ·Daniel J. Weisdorf, Shelly Carter, Dennis L. Confer, James L.M. Ferrara, Mary Horowitz	9
14	Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center. 2007 ·Blood ·Vinod K. Prasad, (unknown), Suhag Parikh, Paul Szabolcs, Timothy A. Driscoll, Kristin Page, Sonali Lakshminarayanan, June Allison, Susan Wood, (unknown), Maria L. Escolar, Paul Martin, Shelly Carter, Joanne Kurtzberg	1
15	National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report 2006 ·Biology of Blood and Marrow Transplantation ·Paul J. Martin, Daniel J. Weisdorf, Donna Przepiorka, Steven Hirschfeld, Ann T. Farrell, J. Douglas Rizzo, Ronan Foley, Gèrard Socié, Shelly Carter, Daniel Couriel, Kirk R. Schultz, Mary E.D. Flowers, Alexandra H. Filipovich, Rima M. Saliba, Georgia B. Vogelsang, Steven Z. Pavletic, Stephanie J. Lee	122
16	Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT) 2005 ·Biology of Blood and Marrow Transplantation ·Kenneth Cornetta, Mary Laughlin, Shelly Carter, Donna A. Wall, Joel Weinthal, Colleen Delaney, John E. Wagner, Robert Sweetman, Philip L. McCarthy, Nelson J. Chao	103
17	Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation 2005 ·Biology of Blood and Marrow Transplantation ·Vincent T. Ho, Corey Cutler, Shelly Carter, Paul J. Martin, (unknown), Mary M. Horowitz, James L.M. Ferrara, Robert J. Soiffer, Sergio Giralt	295
18	Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review 2003 ·Biology of Blood and Marrow Transplantation ·Daniel J. Weisdorf, David D. Hurd, Shelly Carter, Craig Howe, (unknown), John E. Wagner, Don Stablein, John S. Thompson, Nancy A. Kernan	48
19	How Much Subjectivity is Needed to Understand Our Lives Objectively? 2002 ·Qualitative Health Research ·Shelly Carter	15
20	IMPACT OF TRANSFUSIONS AND ACUTE REJECTION ON POSTTRANSPLANTATION DONOR ANTIGEN-SPECIFIC RESPONSES IN TWO STUDY POPULATIONS1,2 1999 ·Transplantation ·Nancy L. Reinsmoen, Arthur J. Matas, Lynn A. Donaldson, Shelly Carter	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact